NL940021I2 - Gezuiverd hematoporfyrinederivaat voor het diagnostiseren en behandelen van tumors, en werkwijze om dit te bereiden. - Google Patents
Gezuiverd hematoporfyrinederivaat voor het diagnostiseren en behandelen van tumors, en werkwijze om dit te bereiden.Info
- Publication number
- NL940021I2 NL940021I2 NL940021C NL940021C NL940021I2 NL 940021 I2 NL940021 I2 NL 940021I2 NL 940021 C NL940021 C NL 940021C NL 940021 C NL940021 C NL 940021C NL 940021 I2 NL940021 I2 NL 940021I2
- Authority
- NL
- Netherlands
- Prior art keywords
- tumors
- molecular weight
- diagnosis
- treatment
- substance
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
- A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
- A61B5/0075—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence by spectroscopy, i.e. measuring spectra, e.g. Raman spectroscopy, infrared absorption spectroscopy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
- A61B5/0082—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence adapted for particular medical purposes
- A61B5/0084—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence adapted for particular medical purposes for introduction into the body, e.g. by catheters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0601—Apparatus for use inside the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0613—Apparatus adapted for a specific treatment
- A61N5/062—Photodynamic therapy, i.e. excitation of an agent
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US42464782A | 1982-09-27 | 1982-09-27 | |
US48134583A | 1983-04-01 | 1983-04-01 |
Publications (2)
Publication Number | Publication Date |
---|---|
NL940021I1 NL940021I1 (nl) | 1997-03-03 |
NL940021I2 true NL940021I2 (nl) | 1997-05-01 |
Family
ID=27026406
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NL940021C NL940021I2 (nl) | 1982-09-27 | 1994-10-26 | Gezuiverd hematoporfyrinederivaat voor het diagnostiseren en behandelen van tumors, en werkwijze om dit te bereiden. |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP0120054B1 (nl) |
JP (1) | JPS60500132A (nl) |
AT (1) | ATE53204T1 (nl) |
AU (1) | AU581840B2 (nl) |
CA (1) | CA1271746A (nl) |
DE (1) | DE3381616D1 (nl) |
DK (1) | DK172284B1 (nl) |
NL (1) | NL940021I2 (nl) |
NO (1) | NO166284C (nl) |
WO (1) | WO1984001382A1 (nl) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4649151A (en) * | 1982-09-27 | 1987-03-10 | Health Research, Inc. | Drugs comprising porphyrins |
US4693885A (en) * | 1984-07-18 | 1987-09-15 | Nippon Petrochemicals Co., Ltd. | Tetrapyrrole therapeutic agents |
US4675338A (en) * | 1984-07-18 | 1987-06-23 | Nippon Petrochemicals Co., Ltd. | Tetrapyrrole therapeutic agents |
US5104637A (en) * | 1985-02-06 | 1992-04-14 | University Of Cincinnati | Radio labeled dihematophorphyrin ether and its use in detecting and treating neoplastic tissue |
US4977177A (en) * | 1985-04-30 | 1990-12-11 | Nippon Petrochemicals Company, Ltd. | Tetrapyrrole polyaminomonocarboxylic acid therapeutic agents |
CA1291710C (en) * | 1985-04-30 | 1991-11-05 | Jerry C. Bommer | Tetrapyrrole therapeutic agents |
US4656186A (en) * | 1985-04-30 | 1987-04-07 | Nippon Petrochemicals Co., Ltd. | Tetrapyrrole therapeutic agents |
US5066274A (en) * | 1985-04-30 | 1991-11-19 | Nippon Petrochemicals Company, Ltd. | Tetrapyrrole therapeutic agents |
GB8522670D0 (en) * | 1985-09-13 | 1985-10-16 | Efamol Ltd | Drug treatments |
EP0220686B1 (en) * | 1985-10-23 | 1992-12-30 | Nihon Medi-Physics Co., Ltd. | Porphyrin derivatives, and their production and use |
ATE87826T1 (de) * | 1986-01-02 | 1993-04-15 | Univ Toledo | Herstellung und verwendung von purpurinen, chlorinen und purpurin und chlorin enthaltenden zubereitungen. |
US5051415A (en) * | 1986-01-02 | 1991-09-24 | The University Of Toledo | Production and use of purpurins, chlorins and purpurin- and chlorin-containing compositions |
US5216012A (en) * | 1986-01-02 | 1993-06-01 | University Of Toledo | Production and use of purpurins, chlorins and purpurin- and chlorin-containing compositions |
US5534506A (en) * | 1986-01-02 | 1996-07-09 | University Of Toledo | Use of purpurins, chlorins and purpurin- and chlorin-containing compositions |
US4882234A (en) * | 1986-11-12 | 1989-11-21 | Healux, Inc. | Storage-stable porphin compositions and a method for their manufacture |
US5283255A (en) * | 1987-01-20 | 1994-02-01 | The University Of British Columbia | Wavelength-specific cytotoxic agents |
US4920143A (en) * | 1987-04-23 | 1990-04-24 | University Of British Columbia | Hydro-monobenzoporphyrin wavelength-specific cytotoxic agents |
US5171749A (en) * | 1987-01-20 | 1992-12-15 | University Of British Columbia | Wavelength-specific cytotoxic agents |
US4925736A (en) * | 1988-07-06 | 1990-05-15 | Long Island Jewish Medical Center | Topical hematoporphyrin |
USRE39094E1 (en) | 1988-07-20 | 2006-05-09 | Health Research, Inc. | Pyropheophorbides and their use in photodynamic therapy |
USRE38994E1 (en) | 1988-07-20 | 2006-02-28 | Health Research, Inc. | Pyropheophorbides conjugates and their use in photodynamic therapy |
GB2254417A (en) * | 1991-04-05 | 1992-10-07 | Bijan Jouza | Photodynamic laser detection for cancer diagnosis |
NL9200143A (nl) * | 1992-01-27 | 1993-08-16 | Seehof Lab F & E Ges | Werkwijze voor de bereiding van een actief middel te gebruiken voor de fotodynamische therapie en voor het vaststellen van een diagnose, therapeutisch middel en diagnosticum dat het actief middel bevat en farmaceutische samenstelling. |
US5948061A (en) | 1996-10-29 | 1999-09-07 | Double Click, Inc. | Method of delivery, targeting, and measuring advertising over networks |
JP5053483B2 (ja) | 1998-08-03 | 2012-10-17 | グーグル インコーポレイティド | 再ターゲット化広告配布のためのネットワーク |
US7897140B2 (en) | 1999-12-23 | 2011-03-01 | Health Research, Inc. | Multi DTPA conjugated tetrapyrollic compounds for phototherapeutic contrast agents |
US7166719B2 (en) | 2002-06-27 | 2007-01-23 | Health Research, Inc. | Fluorinated photosensitizers related to chlorins and bacteriochlorins for photodynamic therapy |
US6624187B1 (en) | 2000-06-12 | 2003-09-23 | Health Research, Inc. | Long wave length absorbing bacteriochlorin alkyl ether analogs |
-
1983
- 1983-09-09 DE DE8383903067T patent/DE3381616D1/de not_active Expired - Lifetime
- 1983-09-09 WO PCT/US1983/001379 patent/WO1984001382A1/en active IP Right Grant
- 1983-09-09 JP JP83503133A patent/JPS60500132A/ja active Pending
- 1983-09-09 AT AT83903067T patent/ATE53204T1/de not_active IP Right Cessation
- 1983-09-09 EP EP83903067A patent/EP0120054B1/en not_active Expired - Lifetime
- 1983-09-09 AU AU20322/83A patent/AU581840B2/en not_active Expired
- 1983-09-15 CA CA000436784A patent/CA1271746A/en not_active Expired - Lifetime
-
1984
- 1984-05-25 NO NO84842089A patent/NO166284C/no not_active IP Right Cessation
- 1984-05-25 DK DK261384A patent/DK172284B1/da active Protection Beyond IP Right Term
-
1994
- 1994-10-26 NL NL940021C patent/NL940021I2/nl unknown
Also Published As
Publication number | Publication date |
---|---|
NO842089L (no) | 1984-05-25 |
NL940021I1 (nl) | 1997-03-03 |
CA1271746A (en) | 1990-07-17 |
EP0120054B1 (en) | 1990-05-30 |
DK261384A (da) | 1984-05-25 |
DK261384D0 (da) | 1984-05-25 |
NO166284B (no) | 1991-03-18 |
EP0120054A4 (en) | 1985-04-11 |
ATE53204T1 (de) | 1990-06-15 |
NO166284C (no) | 1991-06-26 |
DK172284B1 (da) | 1998-02-23 |
WO1984001382A1 (en) | 1984-04-12 |
DE3381616D1 (de) | 1990-07-05 |
JPS60500132A (ja) | 1985-01-31 |
AU2032283A (en) | 1984-04-24 |
AU581840B2 (en) | 1989-03-09 |
EP0120054A1 (en) | 1984-10-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NL940021I2 (nl) | Gezuiverd hematoporfyrinederivaat voor het diagnostiseren en behandelen van tumors, en werkwijze om dit te bereiden. | |
US4564686A (en) | Phosphoric acid diesters or their salts and process for producing the same | |
DE3836006C2 (de) | Monophosphoryllipid-A-Derivate, Verfahren zur Herstellung von Monophosphoryllipid-A-Derivaten und Verwendung von Monophosphoryllipid-A-Derivaten | |
ATE108763T1 (de) | Neue benzocyclohepten-derivate, deren herstellung und verwendung für pharmazeutika. | |
ATE71375T1 (de) | Substituierte 6-fluor-4-oxo-1,4-dihydrochinolin-3-carbonsaeure ; deren derivate; diese verbindung enthaltende pharmazeutische zubereitungen und verfahren zur herstellung dieser verbindungen. | |
ATE25246T1 (de) | Triphenylimidazolyloxyalkansaeuren und ihre derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate. | |
ATE1192T1 (de) | Verfahren zur herstellung von beta-lactam-derivaten, die so erhaltenen neuen derivate sowie diese derivate enthaltende pharmazeutische zusammensetzungen. | |
JPS6055506B2 (ja) | 新規ω−アミノカルボン酸アミドとその製法 | |
EP0036663A1 (de) | Oxiranbuttersäure-Derivate, ihre Herstellung und Verwendung, sowie diese enthaltende Arzneimittel | |
Slocum et al. | The preparation of several N-Substituted and N, N-Disubstituted ferrocenesulfonamides | |
GB2053232A (en) | Dipeptides their preparation and the medicaments in which they are present | |
SU1346046A3 (ru) | Способ получени н-бутиловых эфиров производных N-ацетилмурамилпептидов | |
Wolf et al. | Amides and amino acid derivatives of biotin | |
CA2189297C (en) | Process for preparing 1-substituted pyrrole-3-carboxylic acid derivatives | |
CH640217A5 (en) | Polypeptides, their preparation and pharmaceutical preparations | |
Gabel | Analgestic activity of 1-substituted 2, 5-diphenylpyrroles | |
Nogrady | Potential Cytostatic Carbohydrate Derivatives. I. N-Mustard Urethans | |
DE69017146T2 (de) | Verfahren zur Herstellung von 2-(3-Pyridyl)-Tetrahydrothiopyran-2-carbonsäurethioamid-1-(1R,2R)oxyden, die so erhaltenen 2-(3-Pyridyl)-Tetrahydrothiopyran-2-carbothioamid-1-(1R,2R)oxyde und diese enthaltende pharmazeutische Zusammenstellungen. | |
JPS6185396A (ja) | ホスフアチジルコリンの製造方法 | |
EP0192317B1 (en) | Homocarnosine or acylhomocarnosine salts | |
US3769364A (en) | Carboxyphenyl esters of propenyl and propadienylphosphonic acids | |
EP0285142A2 (en) | 3-Acylamino-3-deoxyallose derivatives | |
JPS5495568A (en) | Novel imidazoleacetic acid derivative | |
SU568632A1 (ru) | Способ выделени транс-6,14-дигидролевопимаровой-6,14-эндо-21-эндо-пропановой кислоты | |
JPH115764A (ja) | 15−デオキシ−イソカルバサイクリン誘導体 |